TC BioPharm (Holdings) plc ADR (TCBP) Shares Up Despite Recent Market Volatility

TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP)’s stock price has soared by 1.09 in relation to previous closing price of 138.50. Nevertheless, the company has seen a gain of 23.16% in its stock price over the last five trading days. Zacks Investment Research reported 2023-11-28 that The FDA clears TC BioPharm’s (TCBP) investigational new drug application seeking approval to begin a clinical study on its pipeline candidate, TCB008, for treating acute myeloid leukemia. Stock declines.

Is It Worth Investing in TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) Right Now?

and a 36-month beta value of 0.29.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

On February 13, 2024, the average trading volume of TCBP was 2.63 shares.

TCBP’s Market Performance

TCBP stock saw a decrease of 23.16% in the past week, with a monthly decline of -55.51% and a quarterly a decrease of -85.84%. The volatility ratio for the week is 23.98%, and the volatility levels for the last 30 days are 16.59% for TC BioPharm (Holdings) plc ADR (TCBP).

TCBP Trading at 2.07% from the 50-Day Moving Average

After a stumble in the market that brought TCBP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.30% of loss for the given period.

Volatility was left at 16.59%, however, over the last 30 days, the volatility rate increased by 23.98%, as shares sank -57.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -85.70% lower at present.

During the last 5 trading sessions, TCBP rose by +23.16%, which changed the moving average for the period of 200-days by -95.90% in comparison to the 20-day moving average, which settled at $1.5289. In addition, TC BioPharm (Holdings) plc ADR saw -65.62% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for TCBP

Equity return is now at value -94.90, with -13.34 for asset returns.


To sum up, TC BioPharm (Holdings) plc ADR (TCBP) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts